K. Cui

ADP plays an important role in mediating platelet aggregation and cyclic flow variations in vivo in stenosed and endothelium-injured canine coronary arteries.

M. Rosolowsky, H. Anderson, C. Benedict, 1992, Circulation research.

Measurement of platelet-activating factor in a canine model of coronary thrombosis and in endarterectomy samples from patients with advanced coronary artery disease.

D. Johnston, J. Willerson, J. McNatt, 1995, Circulation research.

Abolition of Cyclic Flow Variations in Stenosed, Endothelium‐Injured Coronary Arteries in Nonhuman Primates With a Peptide Fragment (VCL) Derived From Human Plasma von Willebrand Factor–Glycoprotein Ib Binding Domain

J. Willerson, L. Buja, A. Mcghie, 1994, Circulation.

Endothelium-Injured Canine Coronary Arteries

M. Rosolowsky, H. Anderson, C. Benedict, 2005 .

Thrombin inhibition enhances tissue-type plasminogen activator-induced thrombolysis and delays reocclusion.

J. Eidt, H. Anderson, J. Willerson, 1992, The American journal of physiology.

Liposome-bound prostaglandin E1 often prevents cyclic flow variations in stenosed and endothelium-injured canine coronary arteries.

H. Anderson, J. Willerson, L. Buja, 1994, Circulation.

Combined ADP and Thromboxane A2 Antagonism Prevents Cyclic Flow Variations in Stenosed and Endothelium‐Injured Arteries in Nonhuman Primates

J. Maffrand, L. Buja, S. Yao, 1993, Circulation.